S01LOcular Vascular Disorder Agents↑ S01SubgroupsAntineovascularisation agentsS01LASubstancesbevacizumabS01LA08afliberceptS01LA05ranibizumabS01LA04faricimabS01LA09verteporfinS01LA01pegaptanibS01LA03